Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255905 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00255905: Completed NA study, sponsored by University of Rochester.
NCT00255905 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00255905, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating insomnia symptoms that are secondary to depression. This study will also determine how long the benefits of CBT will last and how the recurrence of insomnia is associated with the onset of new depressive episodes.
Interventions
- BEHAVIORAL Cognitive behavioral therapy (CBT) for insomnia
- BEHAVIORAL Clinician monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-07 |
| Phase | NA |
What the finished NCT00255905 record still lists
NCT00255905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive behavioral therapy (CBT) for insomnia is the first listed.
NCT00255905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00255905 about?
NCT00255905 is a clinical study titled "Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia". This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating insomnia symptoms that are secondary to depression. This study will also determine how long the benefits of CBT will last and how the recurrence of insomnia is associated with the onset of new depressive ep...
What is the current status of trial NCT00255905?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2004-07. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00255905?
The interventions under investigation include: Cognitive behavioral therapy (CBT) for insomnia (BEHAVIORAL), Clinician monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00255905?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00255905's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia